Where Insulet Stands With Analysts
In the last three months, 6 analysts have published ratings on Insulet (NASDAQ:PODD), offering a diverse range of…
Peeling Back The Layers: Exploring Oscar Health Through Analyst Insights
Ratings for Oscar Health (NYSE:OSCR) were provided by 6 analysts in the past three months, showcasing a mix…
What Analysts Are Saying About Edwards Lifesciences Stock
Edwards Lifesciences (NYSE:EW) has been analyzed by 15 analysts in the last three months, revealing a diverse range…
What Analysts Are Saying About CVS Health Stock
CVS Health (NYSE:CVS) underwent analysis by 17 analysts in the last quarter, revealing a spectrum of viewpoints from…
What’s Going On With Oracle Stock Thursday?
Oracle announces plans for two new cloud regions in Morocco, emphasizing growth opportunities in Africa.
Wall Street On Backfoot As Traders Sweat Over Key Inflation Data: Economist Warns Stock Rally May Stumble If Bond Yield Crosses This Level
U.S. stocks are likely to remain weak on Thursday, major index futures indicated, as lower bond yields stayed elevated and mixed earnings dampened sentiment.
Top 5 Consumer Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies. The…
These Analysts Boost Their Forecasts On Nutanix After Q3 Earnings
Nutanix, Inc. (NASDAQ:NTNX) posted better-than-expected earnings for its third quarter on Wednesday. Nutanix posted adjusted earnings of 28…
Maxeon Solar Technologies Expects Q2 Revenue of $160M-$200M Vs $203.80M Est, Capex of $15M-$25M
Second Quarter 2024 and Fiscal Year 2024 Outlook
For the second quarter of 2024, the Company anticipates the following
These Analysts Slash Their Forecasts On UiPath Following Q1 Results
UiPath, Inc. (NYSE:PATH) reported better-than-expected first-quarter financial results and announced a chief executive officer transition on Wednesday. UiPath…